Terms: = Brain cancer AND TPM3, ENSG00000143549, 7170
15 results:
1. LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients.
Hardin EC; Schmid S; Sommerkamp A; Bodden C; Heipertz AE; Sievers P; Wittmann A; Milde T; Pfister SM; von Deimling A; Horn S; Herz NA; Simon M; Perera AA; Azizi A; Cruz O; Curry S; Van Damme A; Garami M; Hargrave D; Kattamis A; Kotnik BF; Lähteenmäki P; Scheinemann K; Schouten-van Meeteren AYN; Sehested A; Viscardi E; Wormdal OM; Zapotocky M; Ziegler DS; Koch A; Hernáiz Driever P; Witt O; Capper D; Sahm F; Jones DTW; van Tilburg CM
Neuro Oncol; 2023 Nov; 25(11):2087-2097. PubMed ID: 37075810
[TBL] [Abstract] [Full Text] [Related]
2. Sex-Specific Whole-Transcriptome Analysis in the Cerebral Cortex of FAE Offspring.
Mishra NK; Shrinath P; Rao R; Shukla PK
Cells; 2023 Jan; 12(2):. PubMed ID: 36672262
[TBL] [Abstract] [Full Text] [Related]
3. Hospital costs associated with adverse events in people with diabetes in the UK.
Keng MJ; Leal J; Bowman L; Armitage J; Mihaylova B;
Diabetes Obes Metab; 2022 Nov; 24(11):2108-2117. PubMed ID: 35676793
[TBL] [Abstract] [Full Text] [Related]
4. Surrogate vascular input function measurements from the superior sagittal sinus are repeatable and provide tissue-validated kinetic parameters in brain DCE-MRI.
Lewis D; Zhu X; Coope DJ; Zhao S; King AT; Cootes T; Jackson A; Li KL
Sci Rep; 2022 May; 12(1):8737. PubMed ID: 35610281
[TBL] [Abstract] [Full Text] [Related]
5. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract] [Full Text] [Related]
6. Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation.
Yan W; Zhang L; Lv F; Moccia M; Carlomagno F; Landry C; Santoro M; Gosselet F; Frett B; Li HY
Eur J Med Chem; 2021 Apr; 216():113265. PubMed ID: 33652352
[TBL] [Abstract] [Full Text] [Related]
7. Nomograms to predict individual prognosis of patients with squamous cell carcinoma of the urinary bladder.
Zhang G; Li Z; Song D; Fang Z
BMC Cancer; 2019 Dec; 19(1):1200. PubMed ID: 31818271
[TBL] [Abstract] [Full Text] [Related]
8. Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor.
Blessing MM; Blackburn PR; Krishnan C; Harrod VL; Barr Fritcher EG; Zysk CD; Jackson RA; Milosevic D; Nair AA; Davila JI; Balcom JR; Jenkins RB; Halling KC; Kipp BR; Nageswara Rao AA; Laack NN; Daniels DJ; Macon WR; Ida CM
J Neuropathol Exp Neurol; 2019 Nov; 78(11):1011-1021. PubMed ID: 31562743
[TBL] [Abstract] [Full Text] [Related]
9. Molecular characterization of cancers with NTRK gene fusions.
Gatalica Z; Xiu J; Swensen J; Vranic S
Mod Pathol; 2019 Jan; 32(1):147-153. PubMed ID: 30171197
[TBL] [Abstract] [Full Text] [Related]
10. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
Parker BM; Parker JV; Lymperopoulos A; Konda V
J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
[TBL] [Abstract] [Full Text] [Related]
11. Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung cancer Patients in Routine Clinical Practice.
Park S; Ahn BC; Lim SW; Sun JM; Kim HR; Hong MH; Lee SH; Ahn JS; Park K; Choi Y; Cho BC; Ahn MJ
J Thorac Oncol; 2018 Sep; 13(9):1373-1382. PubMed ID: 29883837
[TBL] [Abstract] [Full Text] [Related]
12. Foretinib Overcomes Entrectinib Resistance Associated with the
Nishiyama A; Yamada T; Kita K; Wang R; Arai S; Fukuda K; Tanimoto A; Takeuchi S; Tange S; Tajima A; Furuya N; Kinoshita T; Yano S
Clin Cancer Res; 2018 May; 24(10):2357-2369. PubMed ID: 29463555
[No Abstract] [Full Text] [Related]
13. In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.
Kita K; Arai S; Nishiyama A; Taniguchi H; Fukuda K; Wang R; Yamada T; Takeuchi S; Tange S; Tajima A; Nakada M; Yasumoto K; Motoo Y; Murakami T; Yano S
Cancer Med; 2017 Dec; 6(12):2972-2983. PubMed ID: 29125233
[TBL] [Abstract] [Full Text] [Related]
14. Design and synthesis of a fluorinated quinazoline-based type-II Trk inhibitor as a scaffold for PET radiotracer development.
Bernard-Gauthier V; Mahringer A; Vesnaver M; Fricker G; Schirrmacher R
Bioorg Med Chem Lett; 2017 Jun; 27(12):2771-2775. PubMed ID: 28476569
[TBL] [Abstract] [Full Text] [Related]
15. Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.
Jung KS; Kim SU; Song K; Park JY; Kim DY; Ahn SH; Kim BK; Han KH
Hepatology; 2015 Dec; 62(6):1757-66. PubMed ID: 26249025
[TBL] [Abstract] [Full Text] [Related]
